Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $713.76 | 14 | 64.1% |
| Consulting Fee | $400.00 | 1 | 35.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Neptune Medical Inc. | $400.00 | 1 | $0 (2023) |
| Endogastric Solutions, Inc | $272.55 | 3 | $0 (2023) |
| Phathom Pharmaceuticals, Inc. | $124.98 | 1 | $0 (2024) |
| BOSTON SCIENTIFIC CORPORATION | $115.68 | 2 | $0 (2018) |
| NESTLE HEALTHCARE NUTRITION INC. | $82.24 | 3 | $0 (2023) |
| ABBVIE INC. | $52.39 | 2 | $0 (2024) |
| Ardelyx, Inc. | $43.77 | 2 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $22.15 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $215.20 | 5 | Phathom Pharmaceuticals, Inc. ($124.98) |
| 2023 | $526.20 | 5 | Neptune Medical Inc. ($400.00) |
| 2022 | $125.00 | 1 | Endogastric Solutions, Inc ($125.00) |
| 2021 | $28.09 | 1 | AbbVie Inc. ($28.09) |
| 2019 | $103.59 | 1 | Endogastric Solutions, Inc ($103.59) |
| 2018 | $76.61 | 1 | BOSTON SCIENTIFIC CORPORATION ($76.61) |
| 2017 | $39.07 | 1 | BOSTON SCIENTIFIC CORPORATION ($39.07) |
All Payment Transactions
15 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $24.30 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/06/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $124.98 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/29/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/03/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $23.77 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/20/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.15 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/25/2023 | NESTLE HEALTHCARE NUTRITION INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $27.30 | General |
| Category: GI | ||||||
| 06/13/2023 | NESTLE HEALTHCARE NUTRITION INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $29.87 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 05/17/2023 | Endogastric Solutions, Inc | ESOPHYX (Device) | Food and Beverage | Cash or cash equivalent | $43.96 | General |
| Category: GERD | ||||||
| 04/28/2023 | NESTLE HEALTHCARE NUTRITION INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $25.07 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 03/28/2023 | Neptune Medical Inc. | — | Consulting Fee | Cash or cash equivalent | $400.00 | General |
| 03/08/2022 | Endogastric Solutions, Inc | ESOPHYX (Device) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: GERD | ||||||
| 12/02/2021 | AbbVie Inc. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $28.09 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/11/2019 | Endogastric Solutions, Inc | ESOPHYX (Device) | Food and Beverage | Cash or cash equivalent | $103.59 | General |
| Category: GERD | ||||||
| 11/16/2018 | BOSTON SCIENTIFIC CORPORATION | GENERAL THERAPIES (Device) | Food and Beverage | In-kind items and services | $76.61 | General |
| Category: THERAPIES | ||||||
| 03/03/2017 | BOSTON SCIENTIFIC CORPORATION | RESOLUTION CLIP (Device) | Food and Beverage | In-kind items and services | $39.07 | General |
| Category: BILIARY DEVICES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 802 | 1,091 | $1.1M | $124,928 |
| 2022 | 22 | 797 | 999 | $1.0M | $115,534 |
| 2021 | 18 | 723 | 903 | $1.0M | $122,138 |
| 2020 | 15 | 552 | 728 | $613,525 | $89,371 |
All Medicare Procedures & Services
83 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 89 | 139 | $133,440 | $20,042 | 15.0% |
| 91120 | Test for tone and sensation of rectum and anus | Office | 2023 | 33 | 33 | $68,409 | $15,377 | 22.5% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 61 | 62 | $177,175 | $11,982 | 6.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 57 | 59 | $77,880 | $8,774 | 11.3% |
| 91122 | Study of rectum sensitivity and function | Office | 2023 | 33 | 33 | $40,173 | $8,302 | 20.7% |
| 91010 | Study of esophagus to assess movement | Office | 2023 | 37 | 37 | $39,476 | $7,499 | 19.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 38 | 68 | $46,240 | $6,937 | 15.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 31 | 31 | $42,160 | $5,884 | 14.0% |
| 91037 | Monitoring and recording of esophageal function through nasal tube with electrode | Office | 2023 | 33 | 33 | $29,730 | $5,127 | 17.2% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 51 | 51 | $92,931 | $4,617 | 5.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 35 | 42 | $36,036 | $4,567 | 12.7% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 66 | 67 | $165,578 | $4,423 | 2.7% |
| 90913 | Biofeedback training for bowel or bladder control, each additional 15 minutes | Office | 2023 | 36 | 158 | $24,574 | $4,164 | 16.9% |
| 45390 | Removal of large bowel tissue using a flexible endoscope | Facility | 2023 | 14 | 14 | $22,678 | $4,141 | 18.3% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 27 | 41 | $18,703 | $3,748 | 20.0% |
| 90912 | Biofeedback training for bowel or bladder control, initial 15 minutes | Office | 2023 | 36 | 54 | $21,252 | $3,601 | 16.9% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2023 | 27 | 55 | $8,070 | $1,528 | 18.9% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 12 | 12 | $18,755 | $1,107 | 5.9% |
| 91010 | Study of esophagus to assess movement | Facility | 2023 | 22 | 22 | $6,950 | $1,105 | 15.9% |
| 91035 | Monitoring and recording of esophageal function through a capsule attached to the esophagus wall | Facility | 2023 | 11 | 11 | $4,630 | $694.50 | 15.0% |
| 91037 | Monitoring and recording of esophageal function through nasal tube with electrode | Facility | 2023 | 18 | 18 | $4,810 | $670.24 | 13.9% |
| 99421 | Online digital evaluation and management service for an established patient for up to 7 days, total time 5-10 minutes | Office | 2023 | 35 | 51 | $3,702 | $636.02 | 17.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 94 | 152 | $145,920 | $21,629 | 14.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 68 | 70 | $92,400 | $11,859 | 12.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 59 | 59 | $80,240 | $11,081 | 13.8% |
About Lisa Lin
Lisa Lin is a Gastroenterology healthcare provider based in Beverly Hills, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/22/2012. The National Provider Identifier (NPI) number assigned to this provider is 1427324516.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Lisa Lin has received a total of $1,114 in payments from pharmaceutical and medical device companies, with $215.20 received in 2024. These payments were reported across 15 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($713.76).
As a Medicare-enrolled provider, Lin has provided services to 2,874 Medicare beneficiaries, totaling 3,721 services with total Medicare billing of $451,971. Data is available for 4 years (2020–2023), covering 83 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Beverly Hills, CA
- Active Since 03/22/2012
- Last Updated 07/25/2025
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1427324516
Products in Payments
- ESOPHYX (Device) $272.55
- VOQUEZNA (Drug) $124.98
- GENERAL THERAPIES (Device) $76.61
- ZENPEP (Drug) $54.94
- IBSRELA (Drug) $43.77
- RESOLUTION CLIP (Device) $39.07
- LINZESS (Drug) $28.09
- VOWST (Biological) $27.30
- CREON (Drug) $24.30
- DUPIXENT (Biological) $22.15
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Beverly Hills
Dr. Shahab Mehdizadeh, M.d, M.D
Gastroenterology — Payments: $179,492
Dr. Seper Dezfoli, M.d, M.D
Gastroenterology — Payments: $114,249
Dr. Benjamin Basseri, M.d, M.D
Gastroenterology — Payments: $41,181
Dr. Dale Prokupek, Md, MD
Gastroenterology — Payments: $23,740
Dr. Leo Treyzon, M.d, M.D
Gastroenterology — Payments: $20,829
Dr. Jonathan Ellis, Md, MD
Gastroenterology — Payments: $19,725